Natco Pharma launches generic version of Tenofovir Alafenamide tablets in India

18 Dec 2017 Evaluate

Natco Pharma has launched a generic version of Tenofovir Alafenamide, TAF, 25 mg, a once-daily tablet for the treatment of chronic hepatitis B in adults, under its brand TAFNAT, in India. The drug TAF demonstrates comparable efficacy, with an enhanced renal and bone safety profile as compared to earlier formulation of tenofovir (tenofovir disoproxil fumarate).

TAFNAT is manufactured under license from Medicines Patent Pool (MPP) and Gilead Sciences. Natco priced its generic medicine of TAFNAT at an MRP of Rs 1900 for a monthly pack of 30 tablets for the Indian market.

Natco Pharma was promoted as a private company to be in the business of research, developing, manufacturing and marketing of pharmaceutical substances and finished dosage forms for Indian and International markets.

Natco Pharma Share Price

888.85 -14.70 (-1.63%)
01-Jan-2026 14:23 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1720.75
Dr. Reddys Lab 1249.75
Cipla 1499.90
Zydus Lifesciences 915.00
Lupin 2102.70
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×